Patents by Inventor Robert M. Scarborough, Jr.

Robert M. Scarborough, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Atrial natriuretic/vasodilator peptide compounds
    Patent number: 5258368
    Abstract: Methods, compounds and compositions are provided for inducing natriuresis, diuresis and vasodilatation in mammalian hosts by administering atrial natriuretic/vasodilator peptides to said host. Also provided are methods for producing such peptide compounds.
    Type: Grant
    Filed: April 28, 1992
    Date of Patent: November 2, 1993
    Assignee: Scios Nova, Inc.
    Inventors: John A. Lewicki, Robert M. Scarborough, Jr.
  • Atrial Natriuretic/vasodilator peptide compounds
    Patent number: 5212286
    Abstract: Methods, compounds and compositions are provided for inducing natriuresis, diuresis and vasodilatation in mammalian hosts by administering atrial natriuretic/vasodilator peptides to said host. Also provided are methods for producing such peptide compounds.
    Type: Grant
    Filed: June 5, 1986
    Date of Patent: May 18, 1993
    Assignee: Scios Nova Inc.
    Inventors: John A. Lewicki, Robert M. Scarborough, Jr.
  • Analogs of atrial natriuretic peptides
    Patent number: 4804650
    Abstract: Compounds and compositions comprising synthetic analogs of Atrial Natriuretic Peptides are provided, together with methods for their production and use as natriuretics, diuretics and/or vasodilators, or as intermediates for or modulators of such useful compounds or of native Atrial Natriuretic Peptides.
    Type: Grant
    Filed: March 16, 1988
    Date of Patent: February 14, 1989
    Assignee: Biotechnology Research Associates, J.V.
    Inventors: John A. Lewicki, Robert M. Scarborough, Jr., Lorin K. Johnson
  • Synthetic analogs of atrial natriuretic peptides
    Patent number: 4757048
    Abstract: Compounds and compositions comprising synthetic analogs of Atrial Natriuretic Peptides are provided, together with methods for their production and use as natriuretics, diuretics and/or vasodilators, or as intermediates for or modulators of such useful compounds or of native Atrial Natriuretic Peptides.
    Type: Grant
    Filed: May 28, 1986
    Date of Patent: July 12, 1988
    Assignee: Biotechnology Research Associates J.V.
    Inventors: John A. Lewicki, Robert M. Scarborough, Jr., Lorin K. Johnson